68
Ascentage Pharma Group International
6855.HK · HKSE
$33.92 -0.82% (-$0.28)
1M -5.89%
Market Cap ¥10.9B
P/E Ratio -
Div. Yield -
ROE 172.24%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 19.44x
P/B 8.21x
P/E N/A
Growth
100 /100
Growing Rev. growth 38.67%
Book val. growth 48.01%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 76.41%
Net margin 216.47%
Op. margin 211.14%
Quality
2 /100
Poor ROIC 33.50%
ROE 172.24%
ROA 30.53%
Debt
37 /100
Moderate Debt/Equity 1.49x
Current ratio 1.79x
Int. coverage -22.42x
Stability
26 /100
Unstable Beta 0.67x
Rev. volatility 209.46%
EPS volatility 110.19%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 6855.HK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Dajun Yang
Employees
828
Headquarters
Suzhou
Evenimente viitoare
31 MAR.
Earnings
Upcoming earnings report